Progression of lymphatic vessel dilatation in the presence of living adult Wuchereria bancrofti
- 1 March 2002
- journal article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 96 (2) , 157-161
- https://doi.org/10.1016/s0035-9203(02)90288-9
Abstract
Bancroftian filariasis, a mosquito-transmitted disease commonly known as elephantiasis, is caused by infection with the parasite Wuchereria bancrofti. Infection with this parasite can induce a broad array of chronic debilitating and socially stigmatizing conditions, but the pathogenesis of this morbidity remains obscure. Recent evidence indicates that in filariasis-endemic areas the primary lesion is not lymphatic vessel obstruction but, rather, dilatation. To determine the extent to which lymphatic dilatation occurs in the presence of living adult W. bancrofti, we performed longitudinal ultrasonographic measurements in 80 men (mean age 24 years) in Brazil who had a total of 107 W. bancrofti nests detectable by ultrasound. Initial mean lymphatic vessel diameter at the site of the worms was 3·4 mm (range, 0·7–11·3), and was greater in men with 2 or more nests (3·9 mm) than in those with only one nest (3·0 mm, P = 0·003). During the study period (2–35 months, mean, 13·7), lymphatic vessel diameter increased at the site of 92 (86·0%) adult worm nests. Mean rate of increase of lymphatic vessel diameter was 1·2 mm per person-year (range, 0-0·93 mm per month). In a general linear model, no factors, including treatment with antifilarial drugs, were significantly associated with rate of vessel diameter increase. Thus, lymphatic vessel dilatation progresses in the presence of living adult W. bancrofti; the rate of this progression is heterogeneous. These data suggest that lymphatic dilatation will continue to progress in most infected persons even after mass treatment with currently recommended antifilarial drugs. In addition to interrupting transmission, the global programme for elimination of lymphatic filariasis should address the potential for disease progression in persons who remain infected with adult W. bancrofti.Keywords
This publication has 21 references indexed in Scilit:
- Proposed panel of diagnostic criteria, including the use of ultrasound, to refine the concept of ‘endemic normals’ in lymphatic filariasisTropical Medicine & International Health, 1999
- Direct assessment in vivo of the efficacy of combined single-dose ivermectin and diethylcarbamazine against adult Wuchereria bancroftiTransactions of the Royal Society of Tropical Medicine and Hygiene, 1998
- The silent burden of sexual disability associated with lymphatic filariasisActa Tropica, 1997
- Ultrasonographic assessment of the adulticidal efficacy of repeat high‐dose ivermectin in bancroftian filariasisTropical Medicine & International Health, 1996
- Detection by ultrasound of living adult Wuchereria bancrofti in the female breastMemórias do Instituto Oswaldo Cruz, 1996
- Direct assessment of the adulticidal efficacy of a single dose of ivermectin in bancroftian filariasisTransactions of the Royal Society of Tropical Medicine and Hygiene, 1995
- A new tool to assess the adulticidal efficacy in vivo of antifilarial drugs for bancroftian filariasisTransactions of the Royal Society of Tropical Medicine and Hygiene, 1995
- Ultrasonographic evidence for stability of adult worm location in bancroftian filariasisTransactions of the Royal Society of Tropical Medicine and Hygiene, 1994
- Live Adult Worms Detected by Ultrasonography in Human Bancroftian FilariasisThe American Journal of Tropical Medicine and Hygiene, 1994
- Sex differentials in susceptibility to lymphatic filariasis and implications for maternal child immunityEpidemiology and Infection, 1990